Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
Pfizer, member of Bio Nebraska, and BioNTech announced today that their vaccine candidates received Fast Track designation from the U.S. Food and Drug Administration.
UNMC joins hundreds of med centers worldwide in study on treating critically ill COVID-19 patients
Julie Anderson of the Omaha World-Herald reports that UNMC and Nebraska Medicine have partnered with over 350 other medical centers to improve patient outcomes.
ADS Biotec Announces Immediate Availability of FDA-EUA Authorized COVID-19 Antibody Detection Kits
Bio Nebraska member ADS Biotec announces availability of COVID-19 Antibody kits that detect coronavirus antibodies in human blood samples.
Welcome KPE
We are excited to welcome KPE as a new Bio Nebraska member!
Welcome SeqStream
We are excited to welcome SeqStream as a new Bio Nebraska member!
$70 million expansion will help Nebraska facilities play a key role in COVID-19 vaccine
Omaha World-Herald staff writer Erin Duffy covers Bio Nebraska member, BD, and their expansion’s role in the fight against COVID-19.
Amgen CEO Featured in Forbes
Bio Nebraska member, Amgen, talks to Fortune about testing drugs and beginning clinical trials to treat symptoms of COVID-19.
LI-COR Near-Infrared Assays and Technology Offer Insight to Coronavirus Researchers
LI-COR Biosciences, Bio Nebraska member, continues to support virology researchers with products, tools, and services to better understand COVID-19.
Welcome Staska Pharmaceuticals
We are excited to welcome Staska Pharmaceuticals as a new Bio Nebraska member!
Member Spotlight: University of Nebraska
President Ted Carter talks about his first six months leading the University of Nebraska in the face of COVID-19.